Jon Jones is without a doubt one of the top draws in the UFC right alongside Conor McGregor and Ronda Rousey.
However, Jones failed an out of competition drug test administered by the United States Anti-Doping Agency (USADA) on June 16. Bones tested positive for Hydroxy-clomiphene, an anti-estrogenic agent, and Letrozole metabolite, an aromatase inhibitor — both of which are banned substances in and out of competition.
Worst case scenario had the 29-year-old light-heavyweight looking at two years on the shelf with a lot of money left on the table.
SIGN UP NOW
Want to become a GMS writer? Sign up now and submit a 250-word test article: http://gms.to/haveyoursay4
However, according to UFC president Dana White, things are looking good for one of his prized assets.
“It’s coming back now that it looks like that he did not take the supplement that everybody thought he took, and we will see how this thing plays out,” White said on The Jim Rome Show.
The fact is Jones still tested positive for something and he did not disclose it to the USADA. While White has insinuated it is not as serious as first feared, a fighter must still disclose everything they put in their body leading up to a fight.
“I don’t even know if this is public. I don’t know if I can talk about it. Normally, I talk about anything, but when it comes to medical stuff you can’t do it, but it’s looking like Jon Jones did not do, take the drug that everybody thought he took. It looks like it’s something else.
"So I’ll let this thing play out, and that if that’s true and that’s what USADA and the Nevada State Athletic Commission says happened, it could look good for Jon Jones.”
The New York-native missed out on a huge payday at UFC 200, but in the prime of his life there will be plenty more opportunities ahead.
He's not quite out of the woods yet and may indeed serve a small suspension for his oversight, but he's going to return to the octagon sooner rather than later if White proves to be accurate.